Sugi Predict

Sugi Predict / Compounds / SCHEMBL96069

SCHEMBL96069

SCHEMBL96069

CC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ TDP1 Q9NUW8 3/20 0.59
▸ CA5A P35218 2/20 0.59
▸ FUT7 Q11130 2/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ MAPT P10636 2/20 0.59
▸ SELL P14151 2/20 0.59
▸ SELP P16109 2/20 0.59
▸ CA12 O43570 1/20 0.59
▸ CA1 P00915 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ TP53 P04637 1/20 0.59
▸ CA3 P07451 1/20 0.59
▸ HPGD P15428 1/20 0.59
▸ FUT4 P22083 1/20 0.59
▸ CA4 P22748 1/20 0.59
▸ CA6 P23280 1/20 0.59
▸ DPP4 P27487 1/20 0.59
▸ MAPK1 P28482 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346697 0.85 CA5A (0.50) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL13144722 0.85 CA5A (0.50) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL15495189 0.85 CA5A (0.50) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL14882650 0.84 TTR (0.50) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL31346682 0.84 TTR (0.50) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL2338863 0.82 LMNA (0.84) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL28009479 0.82 LMNA (0.52) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL15128582 0.82 HSD17B1 (0.49) LMNAKDM4ETDP1CA5AFUT7
SCHEMBL24613993 0.82 POLB (0.71) LMNAKDM4ETDP1FUT7CA1
SCHEMBL12359408 0.82 POLB (0.71) LMNAKDM4ETDP1FUT7CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 852 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9492409-B2 Compositions and methods for the treatment of local pain CELLIX BIO PRIVATE LIMITED (IN) 2016-11-15 — — US claimed
US-20150119423-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF LOCAL PAIN CELLIX BIO PRIVATE LIMITED (IN) 2015-04-30 — — US claimed
US-20150090252-A1 APPARATUS AND PROCESS FOR PASTEURIZATION OF SAP AND PRODUCT THEREOF FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) 2015-04-02 — — US claimed
US-20130310332-A1 MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF UNIVERSITY OF RHODE ISLAND (US) 2013-11-21 — — US claimed
US-20130267474-A1 NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF UNIVERSITY OF RHODE ISLAND (US) 2013-10-10 — — US claimed
WO-2012122639-A1 APPARATUS AND PROCESS FOR PASTEURIZATION OF SAP AND PRODUCT THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-09-20 — — WO claimed
EP-1778176-B1 COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES HENKEL AG & CO KGAA (DE) 2012-07-25 — — EP claimed
WO-2012055010-A1 MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-05-03 — — WO claimed
WO-2012021981-A1 NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-02-23 — — WO claimed
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction BIODERM RESEARCH (US) 2008-10-16 — — US claimed
EP-1432388-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 — — EP claimed
WO-2003030847-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 — — EP claimed
EP-1300133-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 — — EP claimed
EP-0498707-B1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent OREAL (FR) 1995-08-02 — — EP claimed
EP-0390496-B1 Intermediates useful for the synthesis of delphinidin chloride IDB HOLDING SPA (IT) 1994-11-30 — — EP claimed
EP-0498707-A1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent L'OREAL (FR) 1992-08-12 — — EP claimed
US-5070212-A INTERMEDIATES USEFUL FOR THE SYNTHESIS OF DELPHINIDIN CHLORIDE IDB HOLDING SPA (IT) 1991-12-03 — — US claimed
EP-0390496-A1 Intermediates useful for the synthesis of delphinidin chloride IDB HOLDING S.p.A. (IT) 1990-10-03 — — EP claimed
US-3931912-A Two-part hair dye or hair bleach package THE GILLETTE COMPANY (US) 1976-01-13 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267474-A1 NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF BPHL, OAT, PSAT1 LMNA 3501/4885KDM4E 3705/4885TDP1 1882/4885
US-20150119423-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF LOCAL PAIN TRPV1, SCN3A, OPRK1 LMNA 3273/4885KDM4E 4784/4885TDP1 1393/4885
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction PSMB1, PLOD3, CUTA LMNA 847/4885KDM4E 513/4885TDP1 3295/4885
US-20130310332-A1 MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF FASN, NNT, MAPK7 LMNA 623/4885KDM4E 4065/4885TDP1 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.